SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4962002 - [SYNAPTOTAGMIN] Nature Reviews Molecular Cell Biology 3, 498 -508 (2002)John McCarthy-8/11/2002
4952002 - [Rapid recruitment of NMDA receptor transport packets to nascent synapsesJohn McCarthy-8/11/2002
4942002 - [ION Channels] ION CHANNELS: A rebellious last-born A new NR3 subunit,John McCarthy-8/11/2002
4932002 - [NMDA Binding] ION CHANNEL STRUCTURE: A long arm to reach you A recentJohn McCarthy-8/11/2002
4922002 - [Memantine:5 Minute Sampler] <B>Owned by:Merz - Private company inJohn McCarthy-8/3/2002
4912002 - [Memantine][BBB and AEA] Modulation of Blood-Brain Barrier Dysfunction aJohn McCarthy-8/3/2002
4902002 - [Memantine NDA][Speculation about 4 outcomes] by Leon Henderson, M.D. BeJohn McCarthy-8/3/2002
4892002 - [Aricept][ARICEPT Versus Than Exelon(R)] Wednesday July 31, 12:27 pm EasJohn McCarthy-8/2/2002
4882002 - [NTII Stock Buyback][500,000 shares] Thursday August 1, 12:17 pm EasternJohn McCarthy-8/1/2002
4872002 - [Memantine NDA Filing][NTII Press Release] Thursday August 1, 12:35 pm EJohn McCarthy-8/1/2002
4862002 - [Memantine NDA Filing][Forest Labs] Thursday August 1, 8:15 am Eastern TJohn McCarthy-8/1/2002
4852002 - [Roche Licenses Compounds to Treat Alzheimer's Disease from Memory PhJohn McCarthy-7/30/2002
4842002 - [DURECT Corporation and Voyager Pharmaceutical Corporation Sign DevelopmeJohn McCarthy-7/29/2002
4832002 - [Stroke Drugs and their Trials] strokecenter.orgJohn McCarthy-7/27/2002
4822002 - [Memantine][Memantine Data Suggest Prevention of Cell Death] Memantine DJohn McCarthy-7/27/2002
4812002 - [Memantine][Caregiver Time] Positive Benefit to Memantine Patients and CJohn McCarthy-7/27/2002
4802002 - [Memantine][1 Year Usage][Dr. Barry Reisberg M.D] Thursday July 25, 8:09John McCarthy-7/27/2002
4792002 - [Antidepressant Efficacy of Memantine] An Investigation of the AntidepreJohn McCarthy-7/27/2002
4782002 - [Memantine][antagonists and antidepressant drugs] 1: Neuropharmacology 2John McCarthy-7/27/2002
4772002 - [Memantine][Combining Memantine & Phenytoin] 1: Exp Eye Res 2002 JunJohn McCarthy-7/27/2002
4762002 - [Memantine][does not block antiaggressive effects of morphine in mice] 1John McCarthy-7/27/2002
4752002 - [Memantine][human plasma by gas ionization/mass spectrometry] 1: J Mass John McCarthy-7/27/2002
4742002 - [Memantine][London New Drugs Group][May] Page 1 London New Drugs Group AJohn McCarthy-7/14/2002
4732001 - [Memantine][Projected costs of Memantien in the U.K.] publichealth.bham.John McCarthy-7/13/2002
4722002 - [New Nitric Oxide Therapeutics] New Nitric Oxide Therapeutics PreliminaJohn McCarthy-7/12/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News